Government to restrict joint bioequivalence until 2013

The government plans to extend the restriction of joint/commissioned bioequivalence testing for the next three years, although the related provision is to expire in November this year.

The Korea Food and Drug Administration said on August 27 that such move is designed to establish more sound market order here.

In its recent survey of 160 representatives in the pharmaceutical field, 66.3 p...